AU2003215062B2 - Secretion, transcription and sporulation genes in Bacillus clausii - Google Patents
Secretion, transcription and sporulation genes in Bacillus clausii Download PDFInfo
- Publication number
- AU2003215062B2 AU2003215062B2 AU2003215062A AU2003215062A AU2003215062B2 AU 2003215062 B2 AU2003215062 B2 AU 2003215062B2 AU 2003215062 A AU2003215062 A AU 2003215062A AU 2003215062 A AU2003215062 A AU 2003215062A AU 2003215062 B2 AU2003215062 B2 AU 2003215062B2
- Authority
- AU
- Australia
- Prior art keywords
- sequence
- protein
- clausii
- sequences
- secretion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000028327 secretion Effects 0.000 title claims description 108
- 241001328122 Bacillus clausii Species 0.000 title claims description 97
- 108090000623 proteins and genes Proteins 0.000 title description 305
- 230000028070 sporulation Effects 0.000 title description 13
- 238000013518 transcription Methods 0.000 title description 8
- 230000035897 transcription Effects 0.000 title description 8
- 150000007523 nucleic acids Chemical class 0.000 claims description 71
- 102000039446 nucleic acids Human genes 0.000 claims description 51
- 108020004707 nucleic acids Proteins 0.000 claims description 51
- 230000014509 gene expression Effects 0.000 claims description 48
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 37
- 125000003729 nucleotide group Chemical group 0.000 claims description 29
- 239000013598 vector Substances 0.000 claims description 29
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 28
- 239000002773 nucleotide Substances 0.000 claims description 25
- 108091003202 SecA Proteins Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 description 180
- 235000018102 proteins Nutrition 0.000 description 173
- 210000004027 cell Anatomy 0.000 description 122
- 238000000034 method Methods 0.000 description 62
- 108091028043 Nucleic acid sequence Proteins 0.000 description 58
- 108090000765 processed proteins & peptides Proteins 0.000 description 55
- 108020004414 DNA Proteins 0.000 description 52
- 102000004196 processed proteins & peptides Human genes 0.000 description 51
- 229920001184 polypeptide Polymers 0.000 description 43
- 235000001014 amino acid Nutrition 0.000 description 33
- 229940024606 amino acid Drugs 0.000 description 32
- 150000001413 amino acids Chemical class 0.000 description 32
- 229940088598 enzyme Drugs 0.000 description 30
- 102000004190 Enzymes Human genes 0.000 description 29
- 108090000790 Enzymes Proteins 0.000 description 29
- 108010076504 Protein Sorting Signals Proteins 0.000 description 26
- 235000014469 Bacillus subtilis Nutrition 0.000 description 25
- 238000003199 nucleic acid amplification method Methods 0.000 description 24
- 230000003321 amplification Effects 0.000 description 23
- 239000013612 plasmid Substances 0.000 description 23
- 244000005700 microbiome Species 0.000 description 21
- 238000004519 manufacturing process Methods 0.000 description 20
- 239000003550 marker Substances 0.000 description 20
- 108091033319 polynucleotide Proteins 0.000 description 20
- 102000040430 polynucleotide Human genes 0.000 description 20
- 239000002157 polynucleotide Substances 0.000 description 20
- 239000013615 primer Substances 0.000 description 20
- 239000000523 sample Substances 0.000 description 19
- 230000001105 regulatory effect Effects 0.000 description 18
- 238000003752 polymerase chain reaction Methods 0.000 description 17
- 238000009396 hybridization Methods 0.000 description 15
- 230000006870 function Effects 0.000 description 14
- 102000035195 Peptidases Human genes 0.000 description 13
- 108091005804 Peptidases Proteins 0.000 description 13
- 230000035772 mutation Effects 0.000 description 13
- 210000000349 chromosome Anatomy 0.000 description 12
- 241000894007 species Species 0.000 description 12
- 230000009466 transformation Effects 0.000 description 12
- 230000001131 transforming effect Effects 0.000 description 12
- 241000006382 Bacillus halodurans Species 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 101150089588 degU gene Proteins 0.000 description 10
- 239000013604 expression vector Substances 0.000 description 10
- 239000003102 growth factor Substances 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- 108091026890 Coding region Proteins 0.000 description 9
- 241000700124 Octodon degus Species 0.000 description 9
- 239000004365 Protease Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 108091034117 Oligonucleotide Proteins 0.000 description 8
- 101150083941 degS gene Proteins 0.000 description 8
- 230000037361 pathway Effects 0.000 description 8
- 102000004127 Cytokines Human genes 0.000 description 7
- 108090000695 Cytokines Proteins 0.000 description 7
- 238000012217 deletion Methods 0.000 description 7
- 230000037430 deletion Effects 0.000 description 7
- 229940088597 hormone Drugs 0.000 description 7
- 239000005556 hormone Substances 0.000 description 7
- 239000002243 precursor Substances 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 108010065511 Amylases Proteins 0.000 description 6
- 102000013142 Amylases Human genes 0.000 description 6
- 108090001060 Lipase Proteins 0.000 description 6
- 102000004882 Lipase Human genes 0.000 description 6
- 239000004367 Lipase Substances 0.000 description 6
- 108700026244 Open Reading Frames Proteins 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 125000000539 amino acid group Chemical group 0.000 description 6
- 235000019418 amylase Nutrition 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 230000002068 genetic effect Effects 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 235000019421 lipase Nutrition 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 230000005945 translocation Effects 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 5
- 108020004511 Recombinant DNA Proteins 0.000 description 5
- 229940025131 amylases Drugs 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 230000000295 complement effect Effects 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000010076 replication Effects 0.000 description 5
- -1 tautomerases Proteins 0.000 description 5
- 230000002103 transcriptional effect Effects 0.000 description 5
- 108010084185 Cellulases Proteins 0.000 description 4
- 102000005575 Cellulases Human genes 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 4
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 108020001507 fusion proteins Proteins 0.000 description 4
- 102000037865 fusion proteins Human genes 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 239000002777 nucleoside Substances 0.000 description 4
- 125000003835 nucleoside group Chemical group 0.000 description 4
- 235000019419 proteases Nutrition 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 230000003362 replicative effect Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000003248 secreting effect Effects 0.000 description 4
- 230000008685 targeting Effects 0.000 description 4
- 108090000145 Bacillolysin Proteins 0.000 description 3
- 101150027068 DEGS1 gene Proteins 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 108090000371 Esterases Proteins 0.000 description 3
- 102000004157 Hydrolases Human genes 0.000 description 3
- 108090000604 Hydrolases Proteins 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 102000004195 Isomerases Human genes 0.000 description 3
- 108090000769 Isomerases Proteins 0.000 description 3
- 108010029541 Laccase Proteins 0.000 description 3
- 108091005507 Neutral proteases Proteins 0.000 description 3
- 102000035092 Neutral proteases Human genes 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 3
- 102000004316 Oxidoreductases Human genes 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000002744 homologous recombination Methods 0.000 description 3
- 230000006801 homologous recombination Effects 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 210000001938 protoplast Anatomy 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 101150108659 secA gene Proteins 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- 108010087967 type I signal peptidase Proteins 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- 239000004382 Amylase Substances 0.000 description 2
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 241000193388 Bacillus thuringiensis Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 2
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010092160 Dactinomycin Proteins 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 101100460773 Geobacillus stearothermophilus nprA gene Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 108010002386 Interleukin-3 Proteins 0.000 description 2
- 102000000646 Interleukin-3 Human genes 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- 108090000301 Membrane transport proteins Proteins 0.000 description 2
- 102000003939 Membrane transport proteins Human genes 0.000 description 2
- 108020005196 Mitochondrial DNA Proteins 0.000 description 2
- 102000005431 Molecular Chaperones Human genes 0.000 description 2
- 108010006519 Molecular Chaperones Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 102000004879 Racemases and epimerases Human genes 0.000 description 2
- 108090001066 Racemases and epimerases Proteins 0.000 description 2
- 108010051611 Signal Recognition Particle Proteins 0.000 description 2
- 102000013598 Signal recognition particle Human genes 0.000 description 2
- 101100095302 Streptococcus gordonii secA1 gene Proteins 0.000 description 2
- 108090000787 Subtilisin Proteins 0.000 description 2
- 108700005078 Synthetic Genes Proteins 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- 108010020764 Transposases Proteins 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 241001659629 Virgibacillus Species 0.000 description 2
- 108700040099 Xylose isomerases Proteins 0.000 description 2
- 229930183665 actinomycin Natural products 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 108010089934 carbohydrase Proteins 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 210000003495 flagella Anatomy 0.000 description 2
- 230000005714 functional activity Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000009655 industrial fermentation Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229940076264 interleukin-3 Drugs 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000002887 multiple sequence alignment Methods 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 101150070927 nprA gene Proteins 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 101150011693 phr gene Proteins 0.000 description 2
- 210000002706 plastid Anatomy 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 108091006106 transcriptional activators Proteins 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- 101710166309 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase Proteins 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- VHTUHGNVVZPWGO-UHFFFAOYSA-N 7-(2-hydroxyethyl)-1,3-dimethyl-8-(pyridin-3-ylmethyl)purine-2,6-dione Chemical compound OCCN1C=2C(=O)N(C)C(=O)N(C)C=2N=C1CC1=CC=CN=C1 VHTUHGNVVZPWGO-UHFFFAOYSA-N 0.000 description 1
- 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 1
- 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 1
- 241001147780 Alicyclobacillus Species 0.000 description 1
- 241001147782 Amphibacillus Species 0.000 description 1
- 241000555286 Aneurinibacillus Species 0.000 description 1
- 241001626813 Anoxybacillus Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000193752 Bacillus circulans Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000193422 Bacillus lentus Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 101100239873 Bacillus subtilis (strain 168) nadR gene Proteins 0.000 description 1
- 101100421919 Bacillus subtilis (strain 168) spo0B gene Proteins 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 108700038091 Beta-glucanases Proteins 0.000 description 1
- 241000555281 Brevibacillus Species 0.000 description 1
- 241000193764 Brevibacillus brevis Species 0.000 description 1
- 210000003771 C cell Anatomy 0.000 description 1
- 101150111062 C gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 108010022152 Corticotropin-Releasing Hormone Proteins 0.000 description 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
- 102000012289 Corticotropin-Releasing Hormone Human genes 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 108010013369 Enteropeptidase Proteins 0.000 description 1
- 102100029727 Enteropeptidase Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 241000321606 Filobacillus Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 101100369308 Geobacillus stearothermophilus nprS gene Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 108050008938 Glucoamylases Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 241001261512 Gracilibacillus Species 0.000 description 1
- 241000193004 Halobacillus Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 108010072039 Histidine kinase Proteins 0.000 description 1
- 101001033279 Homo sapiens Interleukin-3 Proteins 0.000 description 1
- 101000629635 Homo sapiens Signal recognition particle receptor subunit alpha Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 102000005385 Intramolecular Transferases Human genes 0.000 description 1
- 108010031311 Intramolecular Transferases Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091061960 Naked DNA Proteins 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000015336 Nerve Growth Factor Human genes 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 102400000050 Oxytocin Human genes 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 241000179039 Paenibacillus Species 0.000 description 1
- 241000193418 Paenibacillus larvae Species 0.000 description 1
- 241000194109 Paenibacillus lautus Species 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 102000006010 Protein Disulfide-Isomerase Human genes 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000018673 SEC Translocation Channels Human genes 0.000 description 1
- 108010091732 SEC Translocation Channels Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 102100026900 Signal recognition particle receptor subunit alpha Human genes 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 102000005157 Somatostatin Human genes 0.000 description 1
- 108010056088 Somatostatin Proteins 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241001291204 Thermobacillus Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 101100187081 Trichormus variabilis (strain ATCC 29413 / PCC 7937) nifS1 gene Proteins 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 241000321595 Ureibacillus Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000003625 amylolytic effect Effects 0.000 description 1
- 101150009206 aprE gene Proteins 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 229940047120 colony stimulating factors Drugs 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 108010005400 cutinase Proteins 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- 230000003413 degradative effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 229940028334 follicle stimulating hormone Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 101150049376 ftsY gene Proteins 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 230000028996 humoral immune response Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 238000007852 inverse PCR Methods 0.000 description 1
- 101150021879 iscS gene Proteins 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 210000003593 megakaryocyte Anatomy 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- ZAHQPTJLOCWVPG-UHFFFAOYSA-N mitoxantrone dihydrochloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO ZAHQPTJLOCWVPG-UHFFFAOYSA-N 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 101150082753 nifS gene Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 101150105920 npr gene Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 210000001322 periplasm Anatomy 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000004983 pleiotropic effect Effects 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 108020003519 protein disulfide isomerase Proteins 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008020 response regulators Proteins 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 102200124760 rs587777729 Human genes 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 101150055937 secD gene Proteins 0.000 description 1
- 101150114545 secE gene Proteins 0.000 description 1
- 101150065339 secF gene Proteins 0.000 description 1
- 101150004862 secG gene Proteins 0.000 description 1
- 230000009962 secretion pathway Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
- 229960000553 somatostatin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2008216971A AU2008216971B2 (en) | 2002-02-08 | 2008-09-12 | Secretion, transcription and sporulation genes in Bacillus Clausii |
| AU2008216972A AU2008216972B2 (en) | 2002-02-08 | 2008-09-12 | Secretion, transcription and sporulation genes in Bacillus Clausii |
| AU2008216973A AU2008216973B2 (en) | 2002-02-08 | 2008-09-12 | Secretion, transcription and sporulation genes in Bacillus Clausii |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35525802P | 2002-02-08 | 2002-02-08 | |
| US60/355,258 | 2002-02-08 | ||
| PCT/US2003/003534 WO2003066818A2 (en) | 2002-02-08 | 2003-02-06 | Secretion, transcription and sporulation genes in bacillus clausii |
Related Child Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008216971A Division AU2008216971B2 (en) | 2002-02-08 | 2008-09-12 | Secretion, transcription and sporulation genes in Bacillus Clausii |
| AU2008216973A Division AU2008216973B2 (en) | 2002-02-08 | 2008-09-12 | Secretion, transcription and sporulation genes in Bacillus Clausii |
| AU2008216972A Division AU2008216972B2 (en) | 2002-02-08 | 2008-09-12 | Secretion, transcription and sporulation genes in Bacillus Clausii |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003215062A1 AU2003215062A1 (en) | 2003-09-02 |
| AU2003215062B2 true AU2003215062B2 (en) | 2008-06-19 |
Family
ID=27734490
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003215062A Ceased AU2003215062B2 (en) | 2002-02-08 | 2003-02-06 | Secretion, transcription and sporulation genes in Bacillus clausii |
| AU2008216971A Ceased AU2008216971B2 (en) | 2002-02-08 | 2008-09-12 | Secretion, transcription and sporulation genes in Bacillus Clausii |
| AU2008216972A Ceased AU2008216972B2 (en) | 2002-02-08 | 2008-09-12 | Secretion, transcription and sporulation genes in Bacillus Clausii |
| AU2008216973A Ceased AU2008216973B2 (en) | 2002-02-08 | 2008-09-12 | Secretion, transcription and sporulation genes in Bacillus Clausii |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008216971A Ceased AU2008216971B2 (en) | 2002-02-08 | 2008-09-12 | Secretion, transcription and sporulation genes in Bacillus Clausii |
| AU2008216972A Ceased AU2008216972B2 (en) | 2002-02-08 | 2008-09-12 | Secretion, transcription and sporulation genes in Bacillus Clausii |
| AU2008216973A Ceased AU2008216973B2 (en) | 2002-02-08 | 2008-09-12 | Secretion, transcription and sporulation genes in Bacillus Clausii |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US7247450B2 (enExample) |
| EP (1) | EP1487853A4 (enExample) |
| JP (1) | JP2005516613A (enExample) |
| CN (1) | CN1639183A (enExample) |
| AU (4) | AU2003215062B2 (enExample) |
| WO (1) | WO2003066818A2 (enExample) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101395264B (zh) | 2006-02-16 | 2013-01-23 | 花王株式会社 | 重组微生物 |
| JP5140285B2 (ja) * | 2006-02-16 | 2013-02-06 | 花王株式会社 | 組換え微生物 |
| US8198046B2 (en) | 2006-07-11 | 2012-06-12 | Danisco Us Inc. | KEX2 cleavage regions of recombinant fusion proteins |
| US20080026376A1 (en) * | 2006-07-11 | 2008-01-31 | Huaming Wang | KEX2 cleavage regions of recombinant fusion proteins |
| JP5140307B2 (ja) * | 2007-04-10 | 2013-02-06 | 花王株式会社 | 組換え微生物 |
| CN101679489B (zh) * | 2007-05-10 | 2014-05-28 | 丹尼斯科美国公司 | 增加细菌内多肽表达的修饰的分泌系统 |
| JP2009017840A (ja) * | 2007-07-13 | 2009-01-29 | Japan Agengy For Marine-Earth Science & Technology | 外来遺伝子を細胞に安定に保持する方法 |
| US8399310B2 (en) | 2010-10-29 | 2013-03-19 | Freescale Semiconductor, Inc. | Non-volatile memory and logic circuit process integration |
| US8389365B2 (en) | 2011-03-31 | 2013-03-05 | Freescale Semiconductor, Inc. | Non-volatile memory and logic circuit process integration |
| US8564044B2 (en) | 2011-03-31 | 2013-10-22 | Freescale Semiconductor, Inc. | Non-volatile memory and logic circuit process integration |
| US8906764B2 (en) | 2012-01-04 | 2014-12-09 | Freescale Semiconductor, Inc. | Non-volatile memory (NVM) and logic integration |
| US8669158B2 (en) | 2012-01-04 | 2014-03-11 | Mark D. Hall | Non-volatile memory (NVM) and logic integration |
| US8658497B2 (en) | 2012-01-04 | 2014-02-25 | Freescale Semiconductor, Inc. | Non-volatile memory (NVM) and logic integration |
| WO2013107522A1 (en) | 2012-01-20 | 2013-07-25 | Hewlett-Packard Indigo B.V. | Concentrating an ink composition |
| US8951863B2 (en) | 2012-04-06 | 2015-02-10 | Freescale Semiconductor, Inc. | Non-volatile memory (NVM) and logic integration |
| US8722493B2 (en) | 2012-04-09 | 2014-05-13 | Freescale Semiconductor, Inc. | Logic transistor and non-volatile memory cell integration |
| US9087913B2 (en) | 2012-04-09 | 2015-07-21 | Freescale Semiconductor, Inc. | Integration technique using thermal oxide select gate dielectric for select gate and apartial replacement gate for logic |
| US8728886B2 (en) | 2012-06-08 | 2014-05-20 | Freescale Semiconductor, Inc. | Integrating formation of a replacement gate transistor and a non-volatile memory cell using a high-k dielectric |
| US8574987B1 (en) | 2012-06-08 | 2013-11-05 | Freescale Semiconductor, Inc. | Integrating formation of a replacement gate transistor and a non-volatile memory cell using an interlayer dielectric |
| US9111865B2 (en) | 2012-10-26 | 2015-08-18 | Freescale Semiconductor, Inc. | Method of making a logic transistor and a non-volatile memory (NVM) cell |
| US8716089B1 (en) | 2013-03-08 | 2014-05-06 | Freescale Semiconductor, Inc. | Integrating formation of a replacement gate transistor and a non-volatile memory cell having thin film storage |
| US8741719B1 (en) | 2013-03-08 | 2014-06-03 | Freescale Semiconductor, Inc. | Integrating formation of a logic transistor and a non-volatile memory cell using a partial replacement gate technique |
| US9006093B2 (en) | 2013-06-27 | 2015-04-14 | Freescale Semiconductor, Inc. | Non-volatile memory (NVM) and high voltage transistor integration |
| US8871598B1 (en) | 2013-07-31 | 2014-10-28 | Freescale Semiconductor, Inc. | Non-volatile memory (NVM) and high-k and metal gate integration using gate-first methodology |
| US8877585B1 (en) | 2013-08-16 | 2014-11-04 | Freescale Semiconductor, Inc. | Non-volatile memory (NVM) cell, high voltage transistor, and high-K and metal gate transistor integration |
| US9129996B2 (en) | 2013-07-31 | 2015-09-08 | Freescale Semiconductor, Inc. | Non-volatile memory (NVM) cell and high-K and metal gate transistor integration |
| US9082837B2 (en) | 2013-08-08 | 2015-07-14 | Freescale Semiconductor, Inc. | Nonvolatile memory bitcell with inlaid high k metal select gate |
| US9252246B2 (en) | 2013-08-21 | 2016-02-02 | Freescale Semiconductor, Inc. | Integrated split gate non-volatile memory cell and logic device |
| US9082650B2 (en) | 2013-08-21 | 2015-07-14 | Freescale Semiconductor, Inc. | Integrated split gate non-volatile memory cell and logic structure |
| US8932925B1 (en) | 2013-08-22 | 2015-01-13 | Freescale Semiconductor, Inc. | Split-gate non-volatile memory (NVM) cell and device structure integration |
| US9275864B2 (en) | 2013-08-22 | 2016-03-01 | Freescale Semiconductor,Inc. | Method to form a polysilicon nanocrystal thin film storage bitcell within a high k metal gate platform technology using a gate last process to form transistor gates |
| US9136129B2 (en) | 2013-09-30 | 2015-09-15 | Freescale Semiconductor, Inc. | Non-volatile memory (NVM) and high-k and metal gate integration using gate-last methodology |
| US8901632B1 (en) | 2013-09-30 | 2014-12-02 | Freescale Semiconductor, Inc. | Non-volatile memory (NVM) and high-K and metal gate integration using gate-last methodology |
| US9129855B2 (en) | 2013-09-30 | 2015-09-08 | Freescale Semiconductor, Inc. | Non-volatile memory (NVM) and high-k and metal gate integration using gate-first methodology |
| US9231077B2 (en) | 2014-03-03 | 2016-01-05 | Freescale Semiconductor, Inc. | Method of making a logic transistor and non-volatile memory (NVM) cell |
| US9112056B1 (en) | 2014-03-28 | 2015-08-18 | Freescale Semiconductor, Inc. | Method for forming a split-gate device |
| US9252152B2 (en) | 2014-03-28 | 2016-02-02 | Freescale Semiconductor, Inc. | Method for forming a split-gate device |
| US9472418B2 (en) | 2014-03-28 | 2016-10-18 | Freescale Semiconductor, Inc. | Method for forming a split-gate device |
| US9379222B2 (en) | 2014-05-30 | 2016-06-28 | Freescale Semiconductor, Inc. | Method of making a split gate non-volatile memory (NVM) cell |
| US9343314B2 (en) | 2014-05-30 | 2016-05-17 | Freescale Semiconductor, Inc. | Split gate nanocrystal memory integration |
| US9257445B2 (en) | 2014-05-30 | 2016-02-09 | Freescale Semiconductor, Inc. | Method of making a split gate non-volatile memory (NVM) cell and a logic transistor |
| US20170335360A1 (en) * | 2014-10-30 | 2017-11-23 | Merck Sharp & Dohme Corp. | Bacillus megaterium recombinant protein expression system |
| US12065652B2 (en) * | 2017-07-21 | 2024-08-20 | Basf Se | Promoter for heterologous expression |
| CN108929883B (zh) * | 2018-08-06 | 2020-05-01 | 齐鲁工业大学 | 芽孢形成相关基因spoⅡE在影响菌株生长及产酶中的应用 |
| CN108949784B (zh) * | 2018-08-06 | 2020-01-10 | 齐鲁工业大学 | 芽孢形成相关基因sigmaF在产酶中的应用 |
| CN109355303B (zh) * | 2018-11-14 | 2022-05-06 | 天津大学 | 抑制和/或敲除基因在提高单克隆抗体的表达量中的应用 |
| CN109837228B (zh) * | 2019-04-03 | 2020-03-03 | 南京工业大学 | 一株利迪链霉菌及其在防治火疫病中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5264366A (en) | 1984-05-29 | 1993-11-23 | Genencor, Inc. | Protease deficient bacillus |
| US5322770A (en) | 1989-12-22 | 1994-06-21 | Hoffman-Laroche Inc. | Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription |
| JPH05153979A (ja) * | 1991-11-29 | 1993-06-22 | Rikagaku Kenkyusho | ｓｅｃＹタンパク質遺伝子 |
| ATE252641T1 (de) * | 1997-07-15 | 2003-11-15 | Genencor Int | Erhöhung der proteinproduktion in gram-positiven mikroorganismen |
| EP1355931A2 (en) * | 2000-10-06 | 2003-10-29 | Novozymes Biotech, Inc. | Methods for monitoring multiple gene expression |
-
2003
- 2003-02-06 AU AU2003215062A patent/AU2003215062B2/en not_active Ceased
- 2003-02-06 CN CN03804758.6A patent/CN1639183A/zh active Pending
- 2003-02-06 JP JP2003566169A patent/JP2005516613A/ja active Pending
- 2003-02-06 WO PCT/US2003/003534 patent/WO2003066818A2/en not_active Ceased
- 2003-02-06 US US10/502,667 patent/US7247450B2/en not_active Expired - Fee Related
- 2003-02-06 EP EP03710878A patent/EP1487853A4/en not_active Withdrawn
-
2007
- 2007-03-19 US US11/725,899 patent/US7544489B2/en not_active Expired - Fee Related
- 2007-03-19 US US11/725,900 patent/US7544490B2/en not_active Expired - Fee Related
- 2007-03-19 US US11/725,836 patent/US7544488B2/en not_active Expired - Fee Related
-
2008
- 2008-09-12 AU AU2008216971A patent/AU2008216971B2/en not_active Ceased
- 2008-09-12 AU AU2008216972A patent/AU2008216972B2/en not_active Ceased
- 2008-09-12 AU AU2008216973A patent/AU2008216973B2/en not_active Ceased
Non-Patent Citations (2)
| Title |
|---|
| van Wely et al., Microbiology, 2000, vol. 146, pp. 2573-2581 * |
| Widner et al., J. Ind. Microbiol. & Biotechnol., 2000, vol. 25, pp. 204-212 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008216972B2 (en) | 2012-07-26 |
| AU2003215062A1 (en) | 2003-09-02 |
| US7544488B2 (en) | 2009-06-09 |
| AU2008216971B2 (en) | 2012-07-26 |
| WO2003066818A2 (en) | 2003-08-14 |
| EP1487853A4 (en) | 2006-06-28 |
| US7544489B2 (en) | 2009-06-09 |
| US20050209448A1 (en) | 2005-09-22 |
| WO2003066818A3 (en) | 2004-10-07 |
| AU2008216972A1 (en) | 2008-10-09 |
| US20080009033A1 (en) | 2008-01-10 |
| EP1487853A2 (en) | 2004-12-22 |
| AU2008216971A1 (en) | 2008-10-09 |
| AU2008216973B2 (en) | 2012-07-26 |
| AU2008216973A1 (en) | 2008-10-09 |
| CN1639183A (zh) | 2005-07-13 |
| US20070172922A1 (en) | 2007-07-26 |
| US7247450B2 (en) | 2007-07-24 |
| US20070172921A1 (en) | 2007-07-26 |
| US7544490B2 (en) | 2009-06-09 |
| JP2005516613A (ja) | 2005-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003215062B2 (en) | Secretion, transcription and sporulation genes in Bacillus clausii | |
| JP5170793B2 (ja) | バチルスにおけるタンパク質発現の増大 | |
| US20090011463A1 (en) | Pcka Modifications and Enhanced Protein Expression in Bacillus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |